Transgene SA (TNG)
Euronext
0.6850
-0.02 (-3.11%)
Closed
Oct 8, 2026
Day's Range
0.68500.7090
52 wk Range
0.68501.50
Financial Statements - TNG - Transgene SA
Revenue
490.00K▲ 59.6%
Net Income
-37.52M▼ 10.5%Net Margin -7658.0%
EBITDA
-34.88M▼ 12.5%
Free Cash Flow
-37.88M▼ 42.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 490K | 307K | 1.45M | 3.46M | 9.99M | 2.98M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -33.99M | -35.68M | -28.67M | -29.73M | -23.74M | -23.97M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | -37.52M | -33.97M | -22.32M | -32.80M | -19.53M | -17.23M |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -37.52M | -33.97M | -22.32M | -32.80M | -19.53M | -17.23M |
| EPS Basic | -0.26 | -0.29 | -0.22 | -0.33 | -0.21 | -0.21 |
| EPS Diluted | -0.26 | -0.29 | -0.22 | -0.33 | -0.21 | -0.21 |
| Basic Shares Outstanding | 144.53M | 116.66M | 101.49M | 99.50M | 91.11M | 83.84M |
| Diluted Shares Outstanding | 144.53M | 116.66M | 101.49M | 99.50M | 91.11M | 83.84M |
| Ebit | -36.21M | -32.29M | -22.16M | -32M | -19.07M | -15.89M |
| Ebitda | -34.88M | -31M | -20.55M | -30.30M | -16.54M | -14.10M |
| Net Income Continuous Operations | -37.52M | -33.97M | -22.32M | -32.80M | -19.53M | -17.23M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
